Chemotherapy for Tuberculous Meningitis

New England Journal of Medicine

Volumn 374, Issue 2, 2016, Pages 179-181

  Donald, Peter R ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOSALICYLIC ACID; BEDAQUILINE; DELAMANID; ETHIONAMIDE; ISONIAZID; LEVOFLOXACIN; MOXIFLOXACIN; PRETOMANID; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; CHILDHOOD MORTALITY; COMBINATION CHEMOTHERAPY; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG TREATMENT FAILURE; EDITORIAL; HUMAN; HYDROCEPHALUS; INTRACRANIAL PRESSURE; LOW DRUG DOSE; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; TREATMENT DURATION; TREATMENT OUTCOME; TUBERCULOUS MENINGITIS; VIETNAMESE; AIDS-RELATED OPPORTUNISTIC INFECTIONS; FEMALE; MALE; TUBERCULOSIS, MENINGEAL;

AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; FEMALE; HUMANS; LEVOFLOXACIN; MALE; RIFAMPIN; TUBERCULOSIS, MENINGEAL;

EID: 84954288124     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1511990     Document Type: Editorial

References (10)

1. Heemskerk AD, Bang ND, Mai NTH, et al. Intensified antituberculosis therapy in adults with tuberculous meningitis. N Engl J Med 2016; 374:124-34.
2. Donald PR. The chemotherapy of tuberculous meningitis in children and adults. Tuberculosis (Edinb) 2010; 90: 375-92.
3. Ruslami R, Ganiem AR, Dian S, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis 2013; 13: 27-35.
4. Chiang CY. State of the Art series on drug-resistant tuberculosis: it's time to protect fluoroquinolones. Int J Tuberc Lung Dis 2009; 13: 1319.
5. Global Alliance for TB Drug Development. Handbook of antituberculosis agents: introduction. Tuberculosis (Edinb) 2008; 88: 85-6.
6. van Toorn R, Schaaf HS, Laubscher JA, van Elsland SL, Donald PR, Schoeman JF. Short intensified treatment in children with drug-susceptible tuberculous meningitis. Pediatr Infect Dis J 2014; 33: 248-52.
7. Donald PR. Cerebrospinal fluid concentrations of antituber-culosis agents in adults and children. Tuberculosis (Edinb) 2010; 90: 279-92.
8. Mitchison DA. Plasma concentrations of isoniazid in the treatment of tuberculosis. In: Davies DA, Prichard BNC, eds. Biological effects of drugs in relation to their plasma concentration. London: MacMillan, 1973: 169.
9. Hong Kong Chest Service/British Medical Research Council. Controlled trial of 2, 4, and 6 months, three-times-weekly regimens for smear-positive pulmonary tuberculosis including an assessment of a combined preparation of isoniazid, rifampin and pyrazinamide. Am Rev Respir Dis 1991; 143: 700-6.
10. Berning SE, Cherry TA, Iseman MD. Novel treatment of meningitis caused by multidrug-resistant Mycobacterium tuberculosis with intrathecal levofloxacin and amikacin: case report. Clin Infect Dis 2001; 32: 643-6.